Table 1.
Demographic and clinical characteristics of patients with DVT (n = 91)
| Patient characteristics | n | (%) | |
|---|---|---|---|
| Sex | Female | 53 | (58.2) |
| Male | 38 | (41.8) | |
| Age (years) | 16–22 | 4 | (4.4) |
| 23–29 | 25 | (27.5) | |
| 30–36 | 23 | (25.3) | |
| 37–43 | 11 | (12.1) | |
| 44–50 | 7 | (7.7) | |
| 51–57 | 10 | (11.0) | |
| 58–64 | 3 | (3.3) | |
| 65–71 | 8 | (8.8) | |
| Co-morbidities | Cancer | 14 | (15.4) |
| HIV/AIDSa | 10 | (11.0) | |
| Hypertension | 7 | (7.7) | |
| Anemia | 6 | (6.6) | |
| Othersc | 16 | (17.6) | |
| Number of prescribed drugs/patient | Less than 3 | 55 | (60.4) |
| Greater or equal to 3 | 36 | (39.6) | |
| Number of patients with concomitant drugs (n = 38) | Drugs that ↑INRb | 21 | (55.3) |
| Drugs that ↓INR | 13 | (34.2) | |
| Drugs that ↑ or ↓INR | 4 | (10.5) | |
aHIV/AIDS: Human Immunodeficiency Virus/Acquired Immunodeficiency Syndrome
bINR: International normalized ratio
cOthers include venous insufficiency, pulmonary tuberculosis, heart failure, diabetes mellitus, and dyslipidemia